STOCK TITAN
  1. Home
  2. Sec-filings
  3. PTHS
  4. [EFFECT] Pelthos Therapeutics Inc. SEC Filing

[EFFECT] Pelthos Therapeutics Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 9, 2026 4:00 P.M.
Form: S-3
CIK: 0001919246
Company Name: Pelthos Therapeutics Inc.
File Number: 333-293133

Source: View Original Filing on SEC EDGAR

Stock PTHS logo
Pelthos Therapeutics

NYSE:PTHS

PTHS Rankings

#5313 Ranked by Market Cap
N/A Ranked by Dividends

PTHS Latest News

Jan 13, 2026
Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance
Jan 5, 2026
Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice
Dec 23, 2025
Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn
Dec 4, 2025
Pelthos Therapeutics Signs Major Pharmacy Benefit Manager Agreement Expanding Patient Access to ZELSUVMI™ (berdazimer) Topical Gel, 10.3%
Dec 2, 2025
Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

PTHS Latest SEC Filings

Feb 5, 2026
[SCHEDULE 13G/A] Pelthos Therapeutics Inc. Amended Passive Investment Disclosure
Feb 2, 2026
[S-3] Pelthos Therapeutics Inc. Shelf Registration Statement
Jan 13, 2026
[8-K] Pelthos Therapeutics Inc. Reports Material Event
Jan 12, 2026
[8-K] Pelthos Therapeutics Inc. Reports Material Event
Jan 2, 2026
[8-K] Pelthos Therapeutics Inc. Reports Material Event

PTHS Stock Data

71.44M
1.41M
64.2%
10.43%
0.18%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
DURHAM